Breast Cancer After Treatment of Hodgkin's Lymphoma: Risk Factors That Really Matter

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 1, 2009, Pages 69-74

  Alm El Din, Mohamed A ^a   Hughes, Kevin S ^a   Finkelstein, Dianne M ^a   Betts, Keith A ^a   Yock, Torunn I ^a   Tarbell, Nancy J ^a   Aisenberg, Alan C ^a   Taghian, Alphonse G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Breast cancer; Hodgkin's lymphoma; Radiation; Risk

Indexed keywords

SMALL NUCLEAR REACTORS;

AFTER TREATMENTS; BREAST CANCER; BREAST CANCERS; CONFIDENCE INTERVALS; HODGKIN'S LYMPHOMA; HODGKIN'S LYMPHOMAS; MEDICAL RECORDS; NATIONAL CANCER INSTITUTES; RISK FACTORS;

IRRADIATION;

ADULT; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CONFIDENCE INTERVAL; DIAPHRAGM; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; MEDICAL RECORD; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; ADULT; BREAST NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; HODGKIN DISEASE; HUMANS; INCIDENCE; MASSACHUSETTS; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 57649091832     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.03.066     Document Type: Article

References (45)

1. Tarbell N.J., Gelber R.D., Weinstein H.J., et al. Sex differences in risk of second malignant tumours after Hodgkin's disease in childhood. Lancet 341 (1993) 1428-1432
2. Hancock S.L., Tucker M.A., and Hoppe R.T. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85 (1993) 25-31
3. Aisenberg A.C., Finkelstein D.M., Doppke K.P., et al. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer 79 (1997) 1203-1210
4. Bhatia S., Robison L.L., Oberlin O., et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334 (1996) 745-751
5. Wahner-Roedler D.L., Nelson D.F., Croghan I.T., et al. Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience. Mayo Clin Proc 78 (2003) 708-715
6. Travis L.B., Hill D., Dores G.M., et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 97 (2005) 1428-1437
7. Tokunaga M., Land C.E., Yamamoto T., et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980. Radiat Res 112 (1987) 243-272
8. Miller A.B., Howe G.R., Sherman G.J., et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 321 (1989) 1285-1289
9. Shore R.E., Hildreth N., Woodard E., et al. Breast cancer among women given X-ray therapy for acute postpartum mastitis. J Natl Cancer Inst 77 (1986) 689-696
10. Hildreth N.G., Shore R.E., and Dvoretsky P.M. The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 321 (1989) 1281-1284
11. Boice Jr. J.D., Harvey E.B., Blettner M., et al. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326 (1992) 781-785
12. Rothman K.J., and Boice J.D. Epidemiologic analysis with a programmable calculator (1979), Government Printing Office, Washington, DC NIH Publication No. (PHS) 79-1649
13. Breslow N.E., Lubin J.H., Marek P., et al. Multiplicative models and cohort analysis. J Am Stat Assoc 38 (1983) 1-12
14. Kaldor J.M., Day N.E., Band P., et al. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: An international collaborative study among cancer registries. Int J Cancer 39 (1987) 571-585
15. O'Brien P.C., Barton M.B., and Fisher R. Breast cancer following treatment for Hodgkin's disease: The need for screening in a young population. Australasian Radiation Oncology Lymphoma Group (AROLG). Australas Radiol 39 (1995) 271-276
16. Cellai E., Magrini S.M., Masala G., et al. The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: Analysis of a series of 1524 cases consecutively treated at the Florence University Hospital. Int J Radiat Oncol Biol Phys 49 (2001) 1327-1337
17. Wolden S.L., Hancock S.L., Carlson R.W., et al. Management of breast cancer after Hodgkin's disease. J Clin Oncol 18 (2000) 765-772
18. Guibout C., Adjadj E., Rubino C., et al. Malignant breast tumors after radiotherapy for a first cancer during childhood. J Clin Oncol 23 (2005) 197-204
19. Travis L.B., Rabkin C.S., Brown L.M., et al. Cancer survivorship-genetic susceptibility and second primary cancers: Research strategies and recommendations. J Natl Cancer Inst 98 (2006) 15-25
20. Gervais-Fagnou D.D., Girouard C., Laperriere N., et al. Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease. Oncology 57 (1999) 224-231
21. Yahalom J., Petrek J.A., Biddinger P.W., et al. Breast cancer in patients irradiated for Hodgkin's disease: A clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 10 (1992) 1674-1681
22. Ng A.K., Bernardo M.V., Weller E., et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors. Blood 100 (2002) 1989-1996
23. Metayer C., Lynch C.F., Clarke E.A., et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18 (2000) 2435-2443
24. Travis L.B., Curtis R.E., and Boice Jr. J.D. Late effects of treatment for childhood Hodgkin's disease. N Engl J Med 335 (1996) 352-353
25. Tokunaga M., Land C.E., Tokuoka S., et al. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res 138 (1994) 209-223
26. Hodgson D.C., Gilbert E.S., Dores G.M., et al. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol 25 (2007) 1489-1497
27. Ng A.K., Bernardo M.P., Weller E., et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 20 (2002) 2101-2108
28. Salloum E., Doria R., Schubert W., et al. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol 14 (1996) 2435-2443
29. Chung C.T., Bogart J.A., Adams J.F., et al. Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 37 (1997) 405-409
30. Beaty III O., Hudson M.M., Greenwald C., et al. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol 13 (1995) 603-609
31. van Leeuwen F.E., Klokman W.J., Veer M.B., et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18 (2000) 487-497
32. Tucker M.A., Coleman C.N., Cox R.S., et al. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318 (1988) 76-81
33. Boivin J.F., and O'Brien K. Solid cancer risk after treatment of Hodgkin's disease. Cancer 61 (1988) 2541-2546
34. SEER Cancer Statistics Review, 1975-2004. Available at: http://seer.cancer.gov/cgi-bin/csr/1975_2004/search.pl#results. Accessed May 14, 2008.
35. Baral N.E., Larsson L.E., and Mattsson B. Breast cancer following irradiation of the breast. Cancer 40 (1977) 2905-2910
36. Holm L.E., Dahlqvist I., Israelsson A., et al. Malignant thyroid tumors after iodine-131 therapy: A retrospective cohort study. N Engl J Med 303 (1980) 188-191
37. Tinger A., Wasserman T.H., Klein E.E., et al. The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique. Int J Radiat Oncol Biol Phys 37 (1997) 865-870
38. Travis L.B., Hill D.A., Dores G.M., et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290 (2003) 465-475
39. van Leeuwen F.E., Klokman W.J., Stovall M., et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95 (2003) 971-980
40. Zellmer D.L., Wilson J.F., and Janjan N.A. Dosimetry of the breast for determining carcinogenic risk in mantle irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 1343-1351
41. Wolden S.L., Lamborn K.R., Cleary S.F., et al. Second cancers following pediatric Hodgkin's disease. J Clin Oncol 16 (1998) 536-544
42. Nyandoto P., Muhonen T., and Joensuu H. Second cancer among long-term survivors from Hodgkin's disease. Int J Radiat Oncol Biol Phys 42 (1998) 373-378
43. Dietrich P.Y., Henry-Amar M., Cosset J.M., et al. Second primary cancers in patients continuously disease-free from Hodgkin's disease: A protective role for the spleen?. Blood 84 (1994) 1209-1215
44. Swerdlow A.J., Barber J.A., Hudson G.V., et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J Clin Oncol 18 (2000) 498-509
45. Koh E.S., Tran T.H., Heydarian M., et al. A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: Reduction in normal tissue dose and second cancer risk. Radiat Oncol 2 (2007) 13